According to analysis from Data Bridge Market Research, the CBD vape oil market is expected to grow from $113.4 million in 2021 to $8.348 billion in 2029, with an average annual compound growth rate of 71.6%.
Source: Data Bridge
The report pointed out:
The increasing disposable income, rising per capita consumption, evolving global consumer trends, growing awareness of the health benefits of CBD and the harms of tobacco are key drivers behind the growth of Europe's CBD e-liquid market. The demand for e-liquids and e-cigarettes is on the rise, creating further business opportunities for the European CBD market.
Considering the growth of electronic cigarette consumption in the UK, it is foreseeable that there will be an increase in demand for CBD e-liquids in the British market. This will position the UK as the dominant force in the CBD market in Europe.
Factors such as cheaper competitors and government regulations could hinder market growth, while the health risks associated with CBD vaping, such as lung damage, could pose significant challenges to market expansion.
At present, the main players in this market are CBDfx, HempBombs, JustCBD, Le petit vapoteur, Vape Dinner Lady, Malaya Hemp, Marry Jane, Paso, and others.
Reference list/bibliography:
Report: Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2019-2025 A report on the market for CBD vape juice, also known as cannabidiol, presents an analysis of the industry, its size, share, growth, trends, and forecasts from 2019 to 2025.
The main image is sourced from prevention.com.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
